Oncology News

Transarterial radioembolization was a well-tolerated first-line treatment among patients with hepatocellular carcinoma, according to research presented at the International Liver Congress.

Glucose variability was an independent predictor of hepatocellular carcinoma, according to research presented at The International Liver Congress.

Researchers validated a liver cancer risk test algorithm for identifying patients with chronic hepatitis C at low risk for hepatocellular carcinoma, according to a study presented at The Digital International Liver Congress.

The combination of cabozantinib and atezolizumab prolonged PFS compared with sorafenib among patients with previously untreated advanced hepatocellular carcinoma, according to topline data released by one of the agent’s manufacturers.

The C-reactive protein and alpha-fetoprotein in immunotherapy score identified patients with favorable hepatocellular carcinoma disease control and survival, according to a study presented at the International Liver Congress.

Treatment with hepatic arterial infusion chemotherapy in combination with sintilimab allowed for surgical resection and produced survival rates similar to lesser advanced hepatocellular carcinoma, according to a presenter at The International Liver Congress.

An electronic, odor-based tool accurately distinguished pancreatic and ovarian cancer specimens from benign disease and control specimens by analyzing vapors emanating from blood samples, according to results of a small, preliminary study.

Black veterans had a higher prevalence of advanced colorectal neoplasia and colorectal cancer compared with white veterans, according to research published in the Journal of Clinical Gastroenterology.

Fecal immunochemical test improved the efficiency of referrals in patients with new-onset lower gastrointestinal symptoms within a primary health care setting, according to research published in Gut.

Healio Gastroenterology presents the following reports on the top peer-tested stories in May.